SCHEMBL18362599

SCHEMBL18362599

COc1cc(CO)c(CO)c(OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 5/20 0.48
▸ PDE4B Q07343 5/20 0.48
▸ PDE4C Q08493 5/20 0.48
▸ PDE4D Q08499 5/20 0.48
▸ PDE5A O76074 4/20 0.44
▸ PDE1A P54750 4/20 0.44
▸ PDE1B Q01064 4/20 0.44
▸ PDE3B Q13370 4/20 0.44
▸ PDE1C Q14123 4/20 0.44
▸ PDE3A Q14432 4/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ PTPN1 P18031 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.40
▸ APLNR P35414 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17323226 0.90 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL1047858 0.87 ALDH1A1 (0.46) PDE4APDE4BPDE4CPDE4DCYP1A2
SCHEMBL205231 0.83 PDE4A (0.52) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL643649 0.80 CYP1A2 (0.62) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL28538218 0.80 PTPN1 (0.40) PDE4APDE4BPDE4CPDE4DCYP1A2
SCHEMBL14666158 0.80 MAPT (0.50) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL9596755 0.80 PDE4A (0.48) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL3833937 0.80 PDE4A (0.48) PDE4APDE4BPDE4CPDE4DCYP1A2
SCHEMBL5882994 0.79 PDE3B (0.45) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL12404016 0.78 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10167258-B2 Inhibitors of mitochondrial pyruvate dehydrogenase kinase isoforms 1-4 and uses thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-01-01 — — US disclosed
US-20170001958-A1 INHIBITORS OF MITOCHONDRIAL PYRUVATE DEHYDROGENASE KINASE ISOFORMS 1-4 AND USES THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2017-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170001958-A1 INHIBITORS OF MITOCHONDRIAL PYRUVATE DEHYDROGENASE KINASE ISOFORMS 1-4 AND USES THEREOF PDK4, PDK2, PDK3 PDE4A 857/4885PDE4B 867/4885PDE4C 1040/4885
US-10167258-B2 Inhibitors of mitochondrial pyruvate dehydrogenase kinase isoforms 1-4 and uses thereof PDK4, PDK2, PDK3 PDE4A 857/4885PDE4B 867/4885PDE4C 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback